Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.

Hajipour, Fatemeh; Mahdavinia, Masoud; Fereidoonnezhad, Masood

Hajipour, Fatemeh; Mahdavinia, Masoud; Fereidoonnezhad, Masood.

Afiliação

Hajipour F; Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mahdavinia M; Department of Medicinal Chemistry, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Fereidoonnezhad M; Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Anticancer Agents Med Chem ; 22(6): 1149-1158, 2022.

Article em En | MEDLINE | ID: mdl-34259151

Assuntos

Antineoplásicos; Platina; Antineoplásicos/química; Apoptose; Ciclo Celular; Linhagem Celular Tumoral; Proliferação de Células; Cisplatino/farmacologia; DNA/química; Ensaios de Seleção de Medicamentos Antitumorais; Humanos; Células MCF-7; Simulação de Acoplamento Molecular; Platina/química

Palavras-chave

Half-lantern cyclometalated Pt(II)âPt(II) complexes; MTT; apoptosis; cell cycle analysis; cytotoxic activity; molecular docking

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Platina / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google